Preclinical Evaluation of Submillimeter Diameter Microwave Interstitial Hyperthermia Applicators
Source abstract
Abstract
Ultra miniature coaxial cable has been used, with microscopic techniques, to fabricate interstitial hyperthermia applicators having diameters of 0.20 mm, 0.33 mm, and 0.58 mm; commercial applicators have a diameter of 1.1 mm. Animal studies with the 0.33 mm diameter applicators have shown that they produce less local tissue trauma than the larger-diameter devices. All of these applicators operate at 915 MHz and have similar heating patterns because they use the conventional monopole design and the catheters have been approximately scaled to the dimensions of each size applicator. We have measured the heating (SAR) patterns of these applicators in tissue-simulating phantoms, both singly and in arrays, using a miniature electric field probe. As an intermediate step to patient trials, we have examined the ability of these applicators to provide effective heating of perfused tissue, using pig thigh and liver as models. Test results suggest that the durability and power handling capabilities of our submillimeter applicators are adequate for use in patients. These new applicators should be useful in the percutaneous treatment of deep-seated tumors and in intraoperative treatments. The applicators also permit intraluminal or intravascular access to tumors.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Ultrasound and Hyperthermia Applications · Microbial Inactivation Methods · Electromagnetic Fields and Biological Effects
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (8)
Show source-provided references
1. Arcangeli, G., Overgaard, J., Gonzalez, D.G., and Shrivas tava, P.N. 1988. Hyperthermia trials. Intl. J. Radiat. Oncol. Biol. Phys. 14(Suppl 1): S93–S109.10.1016/0360-3016(88)90171-X ↗
2. Cetas, T.C. 1982. The philosophy and use of tissue-equivalent electromagnetic phantoms, pp. 441–461 Physical Aspects of Hyperthermia. Nussbaum, G.H., ed., The American Institute of Physics, New York.
3. Cosset, J.M., Dutreix, J., Haie, C., Gerbaulet, A., Janoray, P., and Dwar, J.A. 1985. Interstitial thennoradiotherapy: a technical and clinical study of 29 implantations performed at the Institut Gustave-Roussy. Intl. J. Hyperthermial: 3–13.10.3109/02656738509029270 ↗
4. Guy, A.W., Chou, C-K, Sorensen, C., McDougall, J.A., Yang, G-Y, and Reynolds, D. 1983. Specific absorption rates of energy in man models exposed to UHF-mob ile-antenna fields. Scientific Report No. 25, Bioelectromagnetics Research Laboratory, University of Washington, Seattle, Washington.
5. Jones, K.M., Ryan, T.P., and Strohbehn, J.W. 1987. An investigation of three potential errors that can occur in common experimental SAR measurements. Proceedings of the Thirteenth Annual Northeast Bioengineering Conference, Philadelphia, PA, pp. 386–389.
6. Luk, K.H. 1987. Clinical indications for interstitial hyperthermia. In: Steeves, R.A., and Paliwal, B.R., eds. Syllabus: A Categorical Course in Radiation Therapy: Hyperthennia. Oak Brook, Illinois; Radiological Society of North America, pp. 111–116.
7. Ryan, T.P. and Strohbehn, J.W. 1987. A comparison of power deposition for three microwave antennas used in hyperthermia cancer therapy. Handout from oral presentation on Nov. 15, 1987, at the Ninth Annual Conference of the IEEE Engineering in Medicine and Biology Society, Boston, MA.
8. Wickersheim, K.A. 1989. Luxtron, Mountain View, CA 94043, personal communication.